Natriuretic peptide family as diagnostic/prognostic biomarker and treatment modality in management of adult and geriatric patients with heart failure:remaining issues and challenges

Zhen-Lu ZHANG; Ran LI; Fei-Yan YANG; Lei XI

doi:10.11909/j.issn.1671-5411.2018.08.008

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>Natriuretic peptide family as diagnostic/prognostic biomarker and treatment modality in management of adult and geriatric patients with heart failure:remaining issues and challenges

DOI: 10.11909/j.issn.1671-5411.2018.08.008

Natriuretic peptide family as diagnostic/prognostic biomarker and treatment modality in management of adult and geriatric patients with heart failure:remaining issues and challenges

Zhen-Lu ZHANG

Ran LI

Fei-Yan YANG

Lei XI

Keywords：Angiotensin-renin-neprilysin-inhibitorsBiomarkerBNPHeart failureNT-proBNP

Publication Date：2018-08-21

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：7( 540-546 )

Journal of Geriatric Cardiology

ISSN：1671-5411

Year, Vol.(Issue)：2018,15(8)